The Human ACL Sheath Exhibits Distinct Transcriptomic Signatures and Functional Properties

Le résumé fourni par la source

The anterior cruciate ligament (ACL) has poor intrinsic healing capacity due to exposure to the intra-articular synovial environment of the knee. Therefore, tendon auto- or allograft reconstruction is the mainstay of treatment for a torn ACL. Following reconstruction, there is a high rate of post-traumatic osteoarthritis, likely due to alteration of joint biomechanics, which supports the clinical need to advance primary ACL repair strategies. The ACL is enclosed by a vascularized, synovial-like sheath (ACL-s), which supplies nutrients to the central core (ACL-c). The ACL-s may act as a selective barrier to solute diffusion, protecting the ACL-c from damaging synovial enzymes and/or hyaluronic acid, while allowing nutrient diffusion. Like the synovium, the ACL-s is rich with collagens and resident macrophages, thus may be susceptible to change of function following injury and inflammation. We investigated the healthy and inflammed ACL-s structure, diffusivity, and cellular profile in comparison to the ACL-c and synovium to guide the development and optimization of primary repair technologies. Diffusion and histologic assessments revealed the ACL-s functions as a semi-permeable barrier through lower solute diffusivity and unique collagen organization. RNAseq demonstrated differential expression of extracellular matrix, inflammatory, and immune-related genes across ACL-s, ACL-c, and synovium, with the ACL-s uniquely showing upregulated expression of CX3CR1 and CLDN5 suggestive of an immunologic barrier. This study establishes the potential of the ACL-s to serve an immunologic and functional barrier that protects the underlying ACL-c from the inflammatory milieu following injury, and therefore, should be recapitulated when developing primary ACL repair technologies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.